Bolzoni Villaret Andrea, Piazza Cesare, Redaelli De Zinis Luca Oscar, Cattaneo Augusto, Cocco Daniela, Peretti Giorgio
Department of Otorhinolaryngology, University of Brescia, Spedali Civili, Piazza Spedali Civili 1, 25123, Brescia, Italy.
Eur Arch Otorhinolaryngol. 2007 Oct;264(10):1179-84. doi: 10.1007/s00405-007-0331-z. Epub 2007 May 30.
Treatment of glottic cancer by CO(2) laser endoscopic cordectomies can be associated with poor vocal outcome when the excision is extended beyond the superficial part of the thyro-arytenoid muscle. Different phonosugical techniques have been described in order to improve postoperative vocal outcome in patients undergoing this type of surgery. We herein present a new device for augmentation of residual vocal cord by video-endoscopic assisted primary intracordal autologous fat injection (PIAFI) performed at the end of transmuscular cordectomy. Twenty-four patients underwent transmuscular cordectomy and PIAFI for Tis and T1a glottic cancer. Eight cc of abdominal fat were obtained during the endoscopic procedure and processed. Infusion of intact parcels of fat tissue was performed to maximally reduce its resorption. PIAFI was performed in the residual vocal cord obtaining its immediate medialization, using a new device that permitted modulated (0.5 cc per click) injection. Fourteen patients were submitted to postoperative voice evaluation including subjective, perceptual, and objective assessment. The results were compared with those of 24 patients treated by transmuscular (Type III) cordectomy without subsequent PIAFI. No complications were observed as a result of PIAFI and the procedure did not significantly prolong overall surgical time. All patients were discharged the day after surgery. Comparison of vocal outcomes according to the Mann-Whitney and Wilcoxon tests showed a positive trend for patients submitted to PIAFI in terms of subjective and objective analysis. By contrast, a statistically significant improvement was reached in terms of perceptual analysis when comparing patients treated by Type III cordectomy alone with those submitted to this kind of procedure followed by PIAFI.
当声门癌的切除范围超出甲状杓状肌浅层时,采用二氧化碳激光内镜下声带切除术治疗可能会导致不良的嗓音预后。为了改善接受此类手术患者的术后嗓音预后,已经描述了不同的发声外科技术。在此,我们介绍一种新装置,用于在经肌肉声带切除术后通过视频内镜辅助的原发性声带内自体脂肪注射(PIAFI)来增厚残余声带。24例Tis和T1a期声门癌患者接受了经肌肉声带切除术和PIAFI。在内镜手术过程中获取8cc腹部脂肪并进行处理。注入完整的脂肪组织块以最大程度减少其吸收。使用一种允许调节(每次点击0.5cc)注射的新装置,在残余声带中进行PIAFI,使其立即向内侧移位。14例患者接受了术后嗓音评估,包括主观、感知和客观评估。将结果与24例接受经肌肉(III型)声带切除术但未进行后续PIAFI治疗的患者的结果进行比较。PIAFI未观察到并发症,且该操作未显著延长总体手术时间。所有患者均在术后第二天出院。根据Mann-Whitney和Wilcoxon检验对嗓音结果进行比较,结果显示接受PIAFI的患者在主观和客观分析方面呈积极趋势。相比之下,在对仅接受III型声带切除术的患者与接受此类手术并随后进行PIAFI的患者进行比较时,在感知分析方面达到了统计学上的显著改善。